buspirone has been researched along with Cognition Disorders in 7 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess effects of a semi-acute administration of buspirone in comparison to a placebo on cognitive function and negative symptoms in patients with schizophrenia and schizoaffective disorder." | 9.14 | Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist. ( Maruff, P; Norman, TR; Olver, JS; Piskulić, D, 2009) |
| "To assess effects of a semi-acute administration of buspirone in comparison to a placebo on cognitive function and negative symptoms in patients with schizophrenia and schizoaffective disorder." | 5.14 | Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist. ( Maruff, P; Norman, TR; Olver, JS; Piskulić, D, 2009) |
| "Studies of buspirone for substance use disorders have had disappointing outcomes, although it may be useful for treating coexisting anxiety and one controlled study suggested efficacy for heroin detoxification." | 2.52 | Buspirone: Back to the Future. ( Howland, RH, 2015) |
| "Ondansetron was without effect on working memory errors, but significantly increased the number of reference memory errors made by the ex-ethanol group." | 1.29 | The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. ( al-Farhan, M; Andrews, N; File, SE; Wu, PY, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Targum, SD | 1 |
| Wedel, PC | 1 |
| Fava, M | 1 |
| Howland, RH | 1 |
| Sumiyoshi, T | 2 |
| Bubenikova-Valesova, V | 1 |
| Horacek, J | 1 |
| Bert, B | 1 |
| Piskulić, D | 1 |
| Olver, JS | 1 |
| Maruff, P | 1 |
| Norman, TR | 1 |
| Olsen, AS | 1 |
| Sozda, CN | 1 |
| Cheng, JP | 1 |
| Hoffman, AN | 1 |
| Kline, AE | 1 |
| Park, S | 1 |
| Jayathilake, K | 1 |
| Roy, A | 1 |
| Ertugrul, A | 1 |
| Meltzer, HY | 1 |
| File, SE | 1 |
| Andrews, N | 1 |
| al-Farhan, M | 1 |
| Wu, PY | 1 |
2 reviews available for buspirone and Cognition Disorders
| Article | Year |
|---|---|
Buspirone: Back to the Future.
Topics: Aggression; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cognition Disorders; Dementia; Depres | 2015 |
Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
Topics: Animals; Behavior; Brain; Buspirone; Cognition Disorders; Humans; Isoindoles; Piperazines; Polymorph | 2008 |
3 trials available for buspirone and Cognition Disorders
| Article | Year |
|---|---|
Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder.
Topics: Acute Disease; Antioxidants; Buspirone; Cognition Disorders; Depressive Disorder, Major; Double-Blin | 2015 |
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Buspirone; Chronic Disease; Cognition Disorders; | 2009 |
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Buspirone; Cognition Disorders; Double-Blind Method; D | 2007 |
2 other studies available for buspirone and Cognition Disorders
| Article | Year |
|---|---|
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.
Topics: Animals; Brain Injuries; Buspirone; Chronic Disease; Cognition Disorders; Disease Models, Animal; Dr | 2012 |
The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits.
Topics: Animals; Anxiety; Buspirone; Cognition Disorders; Ethanol; Exploratory Behavior; Hippocampus; In Vit | 1993 |